Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Del Mastro

Showing results (1-10 of 253) with videos related to

Pageof 26
Sort By:
Tumori|November 11, 2003
[Epoetin in cancer patients. Guidelines of the ASCO and the ASH for evidence-based clinical practice]Lucia Del Mastro, ,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Temporary ovarian suppression with goserelin and ovarian function protection in patients with breast cancer undergoing chemotherapyLucia Del Mastro
Tumori|July 9, 2004
[The AIOM (Italian Association of Medical Oncology) practice guidelines for breast neoplasms]Lucia Del Mastro, ,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast CancerLucia Del Mastro
The Lancet. Oncology|September 7, 2013
Anthracycline-free therapy for HER2-amplified breast cancerAlessandra Gennari, Lucia Del Mastro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Fertility preservation strategies for breast cancer patientsLucia Del Mastro, Marco Venturini
Annals of Translational Medicine|April 3, 2023
Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancerSimone Nardin, Lucia Del Mastro
Minerva Ginecologica|April 12, 2017
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patientsBenedetta Conte, Lucia Del Mastro
Lancet (London, England)|April 7, 2005
ATAC trial updateLucia Del Mastro, Marco Venturini
The Oncologist|October 15, 2015
Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?Lucia Del Mastro, Matteo Lambertini
Pageof 26

Showing results (1-10 of 253) with videos related to

Sort By:
Pageof 26
Tumori|November 11, 2003
[Epoetin in cancer patients. Guidelines of the ASCO and the ASH for evidence-based clinical practice]Lucia Del Mastro, ,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Temporary ovarian suppression with goserelin and ovarian function protection in patients with breast cancer undergoing chemotherapyLucia Del Mastro
Tumori|July 9, 2004
[The AIOM (Italian Association of Medical Oncology) practice guidelines for breast neoplasms]Lucia Del Mastro, ,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2017
Optimal Adjuvant Chemotherapy Regimens for Patients With Early-Stage Breast CancerLucia Del Mastro
The Lancet. Oncology|September 7, 2013
Anthracycline-free therapy for HER2-amplified breast cancerAlessandra Gennari, Lucia Del Mastro
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2006
Fertility preservation strategies for breast cancer patientsLucia Del Mastro, Marco Venturini
Annals of Translational Medicine|April 3, 2023
Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancerSimone Nardin, Lucia Del Mastro
Minerva Ginecologica|April 12, 2017
Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in breast cancer patientsBenedetta Conte, Lucia Del Mastro
Lancet (London, England)|April 7, 2005
ATAC trial updateLucia Del Mastro, Marco Venturini
The Oncologist|October 15, 2015
Temporary Ovarian Suppression With Gonadotropin-Releasing Hormone Agonist During Chemotherapy for Fertility Preservation: Toward the End of the Debate?Lucia Del Mastro, Matteo Lambertini
Pageof 26